Taking people in Németország1. fázis
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
Key facts
- Where
- Cologne, Essen, Munich és Rostock, NémetországSee the 4 sites
- Phase
- 1. fázis
Where in Németország
- University Hospital Cologne AöRCologne, NémetországTaking people
- Universitaetsklinikum Essen (AoR)Essen, NémetországTaking people
- Klinikum rechts der Isar der TU Muenchen AöRMunich, NémetországTaking people
- Rostock University Medical CenterRostock, NémetországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novartis Pharma AG
- Trial code
- EU 2023-510356-23-00
- Record updated
- 2026. május 12.